<DOC>
	<DOC>NCT02941341</DOC>
	<brief_summary>Non-comparative, observational, ambispective post-authorisation study (EPA-SP).</brief_summary>
	<brief_title>Observational Post-Authorisation Study on the Use of Bemfola® in Human Assisted Reproductive Techniques in Spain.</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<criteria>Women aged ≥ 18 years Currently undergoing an IVF or ICSI cycle or are oocytedonors Have completed controlled ovarian stimulation Have received at least 5 doses of Bemfola® Are pituitary suppressed with a GnRH antagonist Have undergone oocyte retrieval Have signed the Informed Consent Form Hypersensitivity to the active substance follitropin alfa, FSH or to any of the excipients listed Presence of tumours of the hypothalamus or pituitary gland</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Bemfola</keyword>
	<keyword>r-hFSH</keyword>
	<keyword>ART</keyword>
	<keyword>Oocytes</keyword>
	<keyword>OHSS</keyword>
	<keyword>Pregnancy</keyword>
</DOC>